410 Medical develops innovative resuscitation technologies for emergency and critical care.

Altis has developed a patent-pending stem cell technology recreating the human intestinal epithelium for compound screening and microbiome research.

Bivarus is a healthcare IT company that has developed an elegant and efficient patient survey platform. Acquired by Press Ganey Associates in January 2018.

G1 Therapeutics, Inc. is a commercial-stage biopharmaceutical company. IPO in May 2017 (NASDAQ: GTHX) Acquired by Pharmacosmos in 2024

MMvention Therapeutix, Inc. is an early-stage biotechnology company focused on discovering and developing novel oral small-molecule therapeutics

Ribometrix is a biotechnology company pioneering a new class of small-molecule therapeutics that directly target the three-dimensional structures of RNA to modulate disease biology.

Stridebio is developing engineered viral vectors for gene therapy. Acquired by Ginkgo Bioworks 2023

Synaptrix is developing a first-in-kind, drug-free neuromodulation therapy for post-operative pain
